Skip to content

Envoy Medical COCH Dividends on preferred shares

Dividends on preferred shares at other companies

Conduent Incorporated logo
Conduent IncorporatedCNDT
$0-100%
Limoneira logo
LimoneiraLMNR
$125K0.0%
AMMO, Inc. logo
AMMO, Inc.POWW
$765.63K-1.1%
James River Group Holdings, Inc.
 logo
James River Group Holdings, Inc. JRVR
$1.97M0.0%
Finance of America Companies logo
Finance of America CompaniesFOA
$1.13M
Texas Capital Bancshares logo
Texas Capital BancsharesTCBI
$4.31M0.0%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DividendsPreferredStock.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's dividends on preferred shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's dividends on preferred shares?
Envoy Medical (COCH) reported dividends on preferred shares of $1.35M in Q1 2026.
How has Envoy Medical's dividends on preferred shares changed year-over-year?
Envoy Medical's dividends on preferred shares increased by 9.0% year-over-year, from $1.24M to $1.35M.
What is the long-term trend for Envoy Medical's dividends on preferred shares?
Over 2 years (2023 to 2025), Envoy Medical's dividends on preferred shares has grown at a 90.7% compound annual growth rate (CAGR), from $1.35M to $4.91M.